| Announce Date | 11/11/2025 |
| EPS Normalized Actual | $0.02 (Miss by $-0.02) |
| EPS GAAP Actual | $0.02 (Miss by $-0.02) |
| Revenue Actual | $0.085484B |
| Revenue Surprise | Beat by $85.484M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.023333 |
| EPS GAAP Estimate | $0.023333 |
| Revenue Estimate | $0.083793B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0.32 | 7.13 | 0.30974 | 0.33485 | 1 |
| Dec 2027 | 0.42 | 5.43 | 0.41468 | 0.4248 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0003 | -0.029925 | 0.085484B | -20.11% | 2.01M |
| FQ2 2025 (Jun 2025) | -0.0142 | -0.0142 | 0.082262B | -16.81% | 82.26M |
| FQ1 2025 (Mar 2025) | -0.01 | -0.01 | 0.088652B | 0.17% | 88.65M |
| FQ4 2024 (Dec 2024) | 0.04 | 0.04 | 0.106932B | 100% | 106.93M |
| FQ3 2024 (Sep 2024) | 0.14 | 0.14 | 0.102672B | 15.01% | 102.67M |
| FQ2 2024 (Jun 2024) | 0.0914 | 0.0914 | 0.096088B | 10.34% | 96.09M |
| FQ1 2024 (Mar 2024) | 0.0047 | 0.0047 | 0.088498B | 5.75% | 88.5M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0B | -INF% | 0M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
0.023333
Consensus Revenue Estimates
0.083793B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.08 | -- | 0.0785002 | 0.0830184 | 1 |
| FQ3 2027 (Sep 2027) | 0.07 | -- | 0.06868767 | 0.0726411 | 1 |
| FQ2 2027 (Jun 2027) | 0.06 | -- | 0.05887515 | 0.0622638 | 1 |
| FQ1 2027 (Mar 2027) | 0.04 | -- | 0.0392501 | 0.0415092 | 1 |
| FQ4 2026 (Dec 2026) | 0.073333 | -- | 0.07224077 | 0.07508695 | 1 |
| FQ3 2026 (Sep 2026) | 0.063333 | 99.53 | 0.06238971 | 0.06484778 | 1 |
| FQ2 2026 (Jun 2026) | 0.04 | 135.5 | 0.03940423 | 0.04095671 | 1 |
| FQ1 2026 (Mar 2026) | 0.023333 | 142.86 | 0.02298548 | 0.02389107 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.1B | -- | 0.1B | 0.1B | 2 |
| FQ3 2027 (Sep 2027) | 0.1B | -- | 0.1B | 0.1B | 2 |
| FQ2 2027 (Jun 2027) | 0.09B | -- | 0.09B | 0.1B | 2 |
| FQ1 2027 (Mar 2027) | 0.09B | -- | 0.09B | 0.09B | 2 |
| FQ4 2026 (Dec 2026) | 0.1B | -- | 0.1B | 0.1B | 1 |
| FQ3 2026 (Sep 2026) | 0.09B | 9.9 | 0.09B | 0.1B | 1 |
| FQ2 2026 (Jun 2026) | 0.09B | 7.75 | 0.09B | 0.09B | 1 |
| FQ1 2026 (Mar 2026) | 0.08B | -5.8 | 0.08B | 0.08B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.030225 | 0.0003 | -0.029925 | -9975% |
| FQ2 2025 (Jun 2025) | -0.0142 | -0.0142 | 100% | |
| FQ1 2025 (Mar 2025) | -0.01 | -0.01 | 100% | |
| FQ4 2024 (Dec 2024) | 0.04 | 0.04 | 100% | |
| FQ3 2024 (Sep 2024) | 0.14 | 0.14 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0914 | 0.0914 | 100% | |
| FQ1 2024 (Mar 2024) | 0.0047 | 0.0047 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.08B | $0.09B | $2.01M | 2.35% |
| FQ2 2025 (Jun 2025) | $0B | $0.08B | $82.26M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.09B | $88.65M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.11B | $106.93M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.1B | $102.67M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.1B | $96.09M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.09B | $88.5M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |